Cargando…

Gonorrhoea and chlamydia diagnosis as an entry point for HIV pre-exposure prophylaxis: a modelling study

OBJECTIVES: Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT) increase the risk of HIV transmission among men who have sex with men (MSM). Diagnosis of NG/CT may provide an efficient entry point for prevention of HIV through the delivery of pre-exposure prophylaxis (PrEP); however, the addit...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasaie, Parastu, Schumacher, Christina M, Jennings, Jacky M, Berry, Stephen A, Tuddenham, Susan A, Shah, Maunank S, Rosenberg, Eli S, Hoover, Karen W, Gift, Thomas L, Chesson, Harrell, German, Danielle, Dowdy, David W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429744/
https://www.ncbi.nlm.nih.gov/pubmed/30837248
http://dx.doi.org/10.1136/bmjopen-2018-023453
_version_ 1783405653982707712
author Kasaie, Parastu
Schumacher, Christina M
Jennings, Jacky M
Berry, Stephen A
Tuddenham, Susan A
Shah, Maunank S
Rosenberg, Eli S
Hoover, Karen W
Gift, Thomas L
Chesson, Harrell
German, Danielle
Dowdy, David W
author_facet Kasaie, Parastu
Schumacher, Christina M
Jennings, Jacky M
Berry, Stephen A
Tuddenham, Susan A
Shah, Maunank S
Rosenberg, Eli S
Hoover, Karen W
Gift, Thomas L
Chesson, Harrell
German, Danielle
Dowdy, David W
author_sort Kasaie, Parastu
collection PubMed
description OBJECTIVES: Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT) increase the risk of HIV transmission among men who have sex with men (MSM). Diagnosis of NG/CT may provide an efficient entry point for prevention of HIV through the delivery of pre-exposure prophylaxis (PrEP); however, the additional population-level impact of targeting PrEP to MSM diagnosed with NG/CT is unknown. DESIGN: An agent-based simulation model of NG/CT and HIV cocirculation among MSM calibrated against census data, disease surveillance reports and the US National HIV Behavioral Surveillance study. SETTING: Baltimore City, Maryland, USA. INTERVENTIONS: PrEP implementation was modelled under three alternative scenarios: (1) PrEP delivery at NG/CT diagnosis (targeted delivery), (2) PrEP evaluation at NG/CT screening/testing and (3) PrEP evaluation in the general community (untargeted). MAIN OUTCOME: The projected incidence of HIV after 20 years of PrEP delivery under two alternatives: when equal numbers of MSM are (1) screened for PrEP or (2) receive PrEP in each year. RESULTS: Assuming 60% uptake and 60% adherence, targeting PrEP to MSM diagnosed with NG/CT could reduce HIV incidence among MSM in Baltimore City by 12.4% (95% uncertainty range (UR) 10.3% to 14.4%) in 20 years, relative to no PrEP. Expanding the coverage of NG/CT screening (such that individuals experience a 50% annual probability of NG/CT screening and evaluation for PrEP on NG/CT diagnosis) can further increase the impact of targeted PrEP to generate a 22.0% (95% UR 20.1% to 23.9%) reduction in HIV incidence within 20 years. When compared with alternative implementation scenarios, PrEP evaluation at NG/CT diagnosis increased impact of PrEP on HIV incidence by 1.5(95% UR 1.1 to 1.9) times relative to a scenario in which PrEP evaluation happened at the time of NG/CT screening/testing and by 1.6 (95% UR 1.2 to 2.2) times relative to evaluating random MSM from the community. CONCLUSIONS: Targeting MSM infected with NG/CT increases the efficiency and effectiveness of PrEP delivery. If high levels of sexually transmitted infection screening can be achieved at the community level, NG/CT diagnosis may be a highly effective entry point for PrEP initialisation.
format Online
Article
Text
id pubmed-6429744
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-64297442019-04-05 Gonorrhoea and chlamydia diagnosis as an entry point for HIV pre-exposure prophylaxis: a modelling study Kasaie, Parastu Schumacher, Christina M Jennings, Jacky M Berry, Stephen A Tuddenham, Susan A Shah, Maunank S Rosenberg, Eli S Hoover, Karen W Gift, Thomas L Chesson, Harrell German, Danielle Dowdy, David W BMJ Open Epidemiology OBJECTIVES: Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT) increase the risk of HIV transmission among men who have sex with men (MSM). Diagnosis of NG/CT may provide an efficient entry point for prevention of HIV through the delivery of pre-exposure prophylaxis (PrEP); however, the additional population-level impact of targeting PrEP to MSM diagnosed with NG/CT is unknown. DESIGN: An agent-based simulation model of NG/CT and HIV cocirculation among MSM calibrated against census data, disease surveillance reports and the US National HIV Behavioral Surveillance study. SETTING: Baltimore City, Maryland, USA. INTERVENTIONS: PrEP implementation was modelled under three alternative scenarios: (1) PrEP delivery at NG/CT diagnosis (targeted delivery), (2) PrEP evaluation at NG/CT screening/testing and (3) PrEP evaluation in the general community (untargeted). MAIN OUTCOME: The projected incidence of HIV after 20 years of PrEP delivery under two alternatives: when equal numbers of MSM are (1) screened for PrEP or (2) receive PrEP in each year. RESULTS: Assuming 60% uptake and 60% adherence, targeting PrEP to MSM diagnosed with NG/CT could reduce HIV incidence among MSM in Baltimore City by 12.4% (95% uncertainty range (UR) 10.3% to 14.4%) in 20 years, relative to no PrEP. Expanding the coverage of NG/CT screening (such that individuals experience a 50% annual probability of NG/CT screening and evaluation for PrEP on NG/CT diagnosis) can further increase the impact of targeted PrEP to generate a 22.0% (95% UR 20.1% to 23.9%) reduction in HIV incidence within 20 years. When compared with alternative implementation scenarios, PrEP evaluation at NG/CT diagnosis increased impact of PrEP on HIV incidence by 1.5(95% UR 1.1 to 1.9) times relative to a scenario in which PrEP evaluation happened at the time of NG/CT screening/testing and by 1.6 (95% UR 1.2 to 2.2) times relative to evaluating random MSM from the community. CONCLUSIONS: Targeting MSM infected with NG/CT increases the efficiency and effectiveness of PrEP delivery. If high levels of sexually transmitted infection screening can be achieved at the community level, NG/CT diagnosis may be a highly effective entry point for PrEP initialisation. BMJ Publishing Group 2019-03-04 /pmc/articles/PMC6429744/ /pubmed/30837248 http://dx.doi.org/10.1136/bmjopen-2018-023453 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Epidemiology
Kasaie, Parastu
Schumacher, Christina M
Jennings, Jacky M
Berry, Stephen A
Tuddenham, Susan A
Shah, Maunank S
Rosenberg, Eli S
Hoover, Karen W
Gift, Thomas L
Chesson, Harrell
German, Danielle
Dowdy, David W
Gonorrhoea and chlamydia diagnosis as an entry point for HIV pre-exposure prophylaxis: a modelling study
title Gonorrhoea and chlamydia diagnosis as an entry point for HIV pre-exposure prophylaxis: a modelling study
title_full Gonorrhoea and chlamydia diagnosis as an entry point for HIV pre-exposure prophylaxis: a modelling study
title_fullStr Gonorrhoea and chlamydia diagnosis as an entry point for HIV pre-exposure prophylaxis: a modelling study
title_full_unstemmed Gonorrhoea and chlamydia diagnosis as an entry point for HIV pre-exposure prophylaxis: a modelling study
title_short Gonorrhoea and chlamydia diagnosis as an entry point for HIV pre-exposure prophylaxis: a modelling study
title_sort gonorrhoea and chlamydia diagnosis as an entry point for hiv pre-exposure prophylaxis: a modelling study
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429744/
https://www.ncbi.nlm.nih.gov/pubmed/30837248
http://dx.doi.org/10.1136/bmjopen-2018-023453
work_keys_str_mv AT kasaieparastu gonorrhoeaandchlamydiadiagnosisasanentrypointforhivpreexposureprophylaxisamodellingstudy
AT schumacherchristinam gonorrhoeaandchlamydiadiagnosisasanentrypointforhivpreexposureprophylaxisamodellingstudy
AT jenningsjackym gonorrhoeaandchlamydiadiagnosisasanentrypointforhivpreexposureprophylaxisamodellingstudy
AT berrystephena gonorrhoeaandchlamydiadiagnosisasanentrypointforhivpreexposureprophylaxisamodellingstudy
AT tuddenhamsusana gonorrhoeaandchlamydiadiagnosisasanentrypointforhivpreexposureprophylaxisamodellingstudy
AT shahmaunanks gonorrhoeaandchlamydiadiagnosisasanentrypointforhivpreexposureprophylaxisamodellingstudy
AT rosenbergelis gonorrhoeaandchlamydiadiagnosisasanentrypointforhivpreexposureprophylaxisamodellingstudy
AT hooverkarenw gonorrhoeaandchlamydiadiagnosisasanentrypointforhivpreexposureprophylaxisamodellingstudy
AT giftthomasl gonorrhoeaandchlamydiadiagnosisasanentrypointforhivpreexposureprophylaxisamodellingstudy
AT chessonharrell gonorrhoeaandchlamydiadiagnosisasanentrypointforhivpreexposureprophylaxisamodellingstudy
AT germandanielle gonorrhoeaandchlamydiadiagnosisasanentrypointforhivpreexposureprophylaxisamodellingstudy
AT dowdydavidw gonorrhoeaandchlamydiadiagnosisasanentrypointforhivpreexposureprophylaxisamodellingstudy